Kisuk Lee

Enablement, Anticipation, And Claim Strategy: Rethinking Biotech Patent Drafting Post-Agilent

Routine Optimization Does Not Necessarily Require A Disclosure Of Ranges Under The Results-Effective Variable Doctrine – Pfizer V. Sanofi, No. 19-1871 (Fed Cir 2024)